Found: 17
Select item for more details and to access through your institution.
The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 1, p. 137, doi. 10.3390/ijms23010137
- By:
- Publication type:
- Article
Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 11, p. 1989, doi. 10.3390/jcm8111989
- By:
- Publication type:
- Article
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.
- Published in:
- Nature Medicine, 2015, v. 21, n. 1, p. 81, doi. 10.1038/nm.3773
- By:
- Publication type:
- Article
IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 7, p. 913, doi. 10.1007/s00262-017-1995-x
- By:
- Publication type:
- Article
Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 12, p. 1451, doi. 10.1007/s00262-016-1892-8
- By:
- Publication type:
- Article
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1081, doi. 10.1007/s00262-014-1580-5
- By:
- Publication type:
- Article
The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 3, p. 489, doi. 10.1007/s00262-012-1351-0
- By:
- Publication type:
- Article
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 953, doi. 10.1007/s00262-011-1004-8
- By:
- Publication type:
- Article
Antagonistic TSC22D1 variants control BRAF<sup>E600</sup>-induced senescence.
- Published in:
- EMBO Journal, 2011, v. 30, n. 9, p. 1753, doi. 10.1038/emboj.2011.95
- By:
- Publication type:
- Article
Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines.
- Published in:
- ChemBioChem, 2021, v. 22, n. 7, p. 1215, doi. 10.1002/cbic.202000687
- By:
- Publication type:
- Article
PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1121973
- By:
- Publication type:
- Article
the Potential and challenges of exploiting the vast But Dynamic Neoepitope Landscape for immunotherapy.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01113
- By:
- Publication type:
- Article
Preclinical evaluation of DISC-GMCSF for the treatment of breast carcinoma.
- Published in:
- Journal of Gene Medicine, 2003, v. 5, n. 5, p. 407, doi. 10.1002/jgm.354
- By:
- Publication type:
- Article
Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK.
- Published in:
- Pigment Cell & Melanoma Research, 2015, v. 28, n. 3, p. 307, doi. 10.1111/pcmr.12364
- By:
- Publication type:
- Article
Near-genomewide RNAi screening for regulators of BRAF<sup>V600E</sup>-induced senescence identifies RASEF, a gene epigenetically silenced in melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2014, v. 27, n. 4, p. 640, doi. 10.1111/pcmr.12248
- By:
- Publication type:
- Article
Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK 13 in primary cutaneous melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2013, v. 26, n. 4, p. 542, doi. 10.1111/pcmr.12096
- By:
- Publication type:
- Article
Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.
- Published in:
- Genome Medicine, 2019, v. 11, n. 1, p. 1, doi. 10.1186/s13073-019-0697-8
- By:
- Publication type:
- Article